Pharma & Healthcare
Global NK-1 Receptor Antagonists Market Research Report 2024
- Nov 05, 24
- ID: 655378
- Pages: 99
- Figures: 105
- Views: 4
NK-1 receptor antagonists are a class of drugs that block the neurokinin-1 (NK1) receptors, which are activated by the neurotransmitter substance P. Substance P plays a key role in the body's vomiting reflex, as well as in pain perception and stress responses. By inhibiting NK1 receptors, these drugs are primarily used to prevent and treat nausea and vomiting, particularly those caused by chemotherapy, radiation therapy, or surgery.
The global NK-1 Receptor Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for NK-1 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NK-1 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of NK-1 Receptor Antagonists include Merck, TerSera Therapeutics, Helsinn Healthcare, Heron Therapeutics, Sandoz, Glenmark, Torrent Pharmaceuticals, Steriscience, Mylan, Fresenius Kabi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for NK-1 Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK-1 Receptor Antagonists.
The NK-1 Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global NK-1 Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK-1 Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
TerSera Therapeutics
Helsinn Healthcare
Heron Therapeutics
Sandoz
Glenmark
Torrent Pharmaceuticals
Steriscience
Mylan
Fresenius Kabi
MSN
Teva
Eugia Pharma
Lupin
Dr. Reddy's Laboratories
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Beijing Sihuan Pharmaceutical
Yichang Humanwell Pharmaceutical
Hansoh Pharma
Segment by Type
Aprepitant
Rolapitant
Fosaprepitant
Netupitant
Maropitant
Other
Segment by Application
Chemotherapy-induced Nausea and Vomiting (CINV)
Postoperative Nausea and Vomiting (PONV)
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NK-1 Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NK-1 Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global NK-1 Receptor Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for NK-1 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NK-1 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of NK-1 Receptor Antagonists include Merck, TerSera Therapeutics, Helsinn Healthcare, Heron Therapeutics, Sandoz, Glenmark, Torrent Pharmaceuticals, Steriscience, Mylan, Fresenius Kabi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for NK-1 Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK-1 Receptor Antagonists.
The NK-1 Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global NK-1 Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK-1 Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
TerSera Therapeutics
Helsinn Healthcare
Heron Therapeutics
Sandoz
Glenmark
Torrent Pharmaceuticals
Steriscience
Mylan
Fresenius Kabi
MSN
Teva
Eugia Pharma
Lupin
Dr. Reddy's Laboratories
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Beijing Sihuan Pharmaceutical
Yichang Humanwell Pharmaceutical
Hansoh Pharma
Segment by Type
Aprepitant
Rolapitant
Fosaprepitant
Netupitant
Maropitant
Other
Segment by Application
Chemotherapy-induced Nausea and Vomiting (CINV)
Postoperative Nausea and Vomiting (PONV)
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NK-1 Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NK-1 Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 NK-1 Receptor Antagonists Market Overview
1.1 Product Definition
1.2 NK-1 Receptor Antagonists by Type
1.2.1 Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 Aprepitant
1.2.3 Rolapitant
1.2.4 Fosaprepitant
1.2.5 Netupitant
1.2.6 Maropitant
1.2.7 Other
1.3 NK-1 Receptor Antagonists by Application
1.3.1 Global NK-1 Receptor Antagonists Market Value by Application (2024-2030)
1.3.2 Chemotherapy-induced Nausea and Vomiting (CINV)
1.3.3 Postoperative Nausea and Vomiting (PONV)
1.3.4 Other
1.4 Global NK-1 Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global NK-1 Receptor Antagonists Revenue 2019-2030
1.4.2 Global NK-1 Receptor Antagonists Sales 2019-2030
1.4.3 Global NK-1 Receptor Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 NK-1 Receptor Antagonists Market Competition by Manufacturers
2.1 Global NK-1 Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global NK-1 Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global NK-1 Receptor Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of NK-1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NK-1 Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NK-1 Receptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of NK-1 Receptor Antagonists, Date of Enter into This Industry
2.8 Global NK-1 Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global NK-1 Receptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest NK-1 Receptor Antagonists Players Market Share by Revenue
2.8.3 Global NK-1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global NK-1 Receptor Antagonists Market Scenario by Region
3.1 Global NK-1 Receptor Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global NK-1 Receptor Antagonists Sales by Region: 2019-2030
3.2.1 Global NK-1 Receptor Antagonists Sales by Region: 2019-2024
3.2.2 Global NK-1 Receptor Antagonists Sales by Region: 2025-2030
3.3 Global NK-1 Receptor Antagonists Revenue by Region: 2019-2030
3.3.1 Global NK-1 Receptor Antagonists Revenue by Region: 2019-2024
3.3.2 Global NK-1 Receptor Antagonists Revenue by Region: 2025-2030
3.4 North America NK-1 Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.4.3 North America NK-1 Receptor Antagonists Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe NK-1 Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.5.3 Europe NK-1 Receptor Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NK-1 Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific NK-1 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific NK-1 Receptor Antagonists Sales by Region (2019-2030)
3.6.3 Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NK-1 Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.7.3 Latin America NK-1 Receptor Antagonists Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NK-1 Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa NK-1 Receptor Antagonists Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NK-1 Receptor Antagonists Sales by Type (2019-2030)
4.1.1 Global NK-1 Receptor Antagonists Sales by Type (2019-2024)
4.1.2 Global NK-1 Receptor Antagonists Sales by Type (2025-2030)
4.1.3 Global NK-1 Receptor Antagonists Sales Market Share by Type (2019-2030)
4.2 Global NK-1 Receptor Antagonists Revenue by Type (2019-2030)
4.2.1 Global NK-1 Receptor Antagonists Revenue by Type (2019-2024)
4.2.2 Global NK-1 Receptor Antagonists Revenue by Type (2025-2030)
4.2.3 Global NK-1 Receptor Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global NK-1 Receptor Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global NK-1 Receptor Antagonists Sales by Application (2019-2030)
5.1.1 Global NK-1 Receptor Antagonists Sales by Application (2019-2024)
5.1.2 Global NK-1 Receptor Antagonists Sales by Application (2025-2030)
5.1.3 Global NK-1 Receptor Antagonists Sales Market Share by Application (2019-2030)
5.2 Global NK-1 Receptor Antagonists Revenue by Application (2019-2030)
5.2.1 Global NK-1 Receptor Antagonists Revenue by Application (2019-2024)
5.2.2 Global NK-1 Receptor Antagonists Revenue by Application (2025-2030)
5.2.3 Global NK-1 Receptor Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global NK-1 Receptor Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck NK-1 Receptor Antagonists Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 TerSera Therapeutics
6.2.1 TerSera Therapeutics Company Information
6.2.2 TerSera Therapeutics Description and Business Overview
6.2.3 TerSera Therapeutics NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 TerSera Therapeutics NK-1 Receptor Antagonists Product Portfolio
6.2.5 TerSera Therapeutics Recent Developments/Updates
6.3 Helsinn Healthcare
6.3.1 Helsinn Healthcare Company Information
6.3.2 Helsinn Healthcare Description and Business Overview
6.3.3 Helsinn Healthcare NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Helsinn Healthcare NK-1 Receptor Antagonists Product Portfolio
6.3.5 Helsinn Healthcare Recent Developments/Updates
6.4 Heron Therapeutics
6.4.1 Heron Therapeutics Company Information
6.4.2 Heron Therapeutics Description and Business Overview
6.4.3 Heron Therapeutics NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Heron Therapeutics NK-1 Receptor Antagonists Product Portfolio
6.4.5 Heron Therapeutics Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz NK-1 Receptor Antagonists Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Glenmark
6.6.1 Glenmark Company Information
6.6.2 Glenmark Description and Business Overview
6.6.3 Glenmark NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Glenmark NK-1 Receptor Antagonists Product Portfolio
6.6.5 Glenmark Recent Developments/Updates
6.7 Torrent Pharmaceuticals
6.7.1 Torrent Pharmaceuticals Company Information
6.7.2 Torrent Pharmaceuticals Description and Business Overview
6.7.3 Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Torrent Pharmaceuticals NK-1 Receptor Antagonists Product Portfolio
6.7.5 Torrent Pharmaceuticals Recent Developments/Updates
6.8 Steriscience
6.8.1 Steriscience Company Information
6.8.2 Steriscience Description and Business Overview
6.8.3 Steriscience NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Steriscience NK-1 Receptor Antagonists Product Portfolio
6.8.5 Steriscience Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan NK-1 Receptor Antagonists Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Company Information
6.10.2 Fresenius Kabi Description and Business Overview
6.10.3 Fresenius Kabi NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fresenius Kabi NK-1 Receptor Antagonists Product Portfolio
6.10.5 Fresenius Kabi Recent Developments/Updates
6.11 MSN
6.11.1 MSN Company Information
6.11.2 MSN Description and Business Overview
6.11.3 MSN NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MSN NK-1 Receptor Antagonists Product Portfolio
6.11.5 MSN Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva NK-1 Receptor Antagonists Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Eugia Pharma
6.13.1 Eugia Pharma Company Information
6.13.2 Eugia Pharma Description and Business Overview
6.13.3 Eugia Pharma NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Eugia Pharma NK-1 Receptor Antagonists Product Portfolio
6.13.5 Eugia Pharma Recent Developments/Updates
6.14 Lupin
6.14.1 Lupin Company Information
6.14.2 Lupin Description and Business Overview
6.14.3 Lupin NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lupin NK-1 Receptor Antagonists Product Portfolio
6.14.5 Lupin Recent Developments/Updates
6.15 Dr. Reddy's Laboratories
6.15.1 Dr. Reddy's Laboratories Company Information
6.15.2 Dr. Reddy's Laboratories Description and Business Overview
6.15.3 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product Portfolio
6.15.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.16 Chia Tai Tianqing Pharmaceutical
6.16.1 Chia Tai Tianqing Pharmaceutical Company Information
6.16.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.16.3 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.16.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.17 Qilu Pharmaceutical
6.17.1 Qilu Pharmaceutical Company Information
6.17.2 Qilu Pharmaceutical Description and Business Overview
6.17.3 Qilu Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Qilu Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.17.5 Qilu Pharmaceutical Recent Developments/Updates
6.18 Beijing Sihuan Pharmaceutical
6.18.1 Beijing Sihuan Pharmaceutical Company Information
6.18.2 Beijing Sihuan Pharmaceutical Description and Business Overview
6.18.3 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.18.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
6.19 Yichang Humanwell Pharmaceutical
6.19.1 Yichang Humanwell Pharmaceutical Company Information
6.19.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.19.3 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.19.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.20 Hansoh Pharma
6.20.1 Hansoh Pharma Company Information
6.20.2 Hansoh Pharma Description and Business Overview
6.20.3 Hansoh Pharma NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Hansoh Pharma NK-1 Receptor Antagonists Product Portfolio
6.20.5 Hansoh Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NK-1 Receptor Antagonists Industry Chain Analysis
7.2 NK-1 Receptor Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NK-1 Receptor Antagonists Production Mode & Process
7.4 NK-1 Receptor Antagonists Sales and Marketing
7.4.1 NK-1 Receptor Antagonists Sales Channels
7.4.2 NK-1 Receptor Antagonists Distributors
7.5 NK-1 Receptor Antagonists Customers
8 NK-1 Receptor Antagonists Market Dynamics
8.1 NK-1 Receptor Antagonists Industry Trends
8.2 NK-1 Receptor Antagonists Market Drivers
8.3 NK-1 Receptor Antagonists Market Challenges
8.4 NK-1 Receptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 NK-1 Receptor Antagonists by Type
1.2.1 Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 Aprepitant
1.2.3 Rolapitant
1.2.4 Fosaprepitant
1.2.5 Netupitant
1.2.6 Maropitant
1.2.7 Other
1.3 NK-1 Receptor Antagonists by Application
1.3.1 Global NK-1 Receptor Antagonists Market Value by Application (2024-2030)
1.3.2 Chemotherapy-induced Nausea and Vomiting (CINV)
1.3.3 Postoperative Nausea and Vomiting (PONV)
1.3.4 Other
1.4 Global NK-1 Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global NK-1 Receptor Antagonists Revenue 2019-2030
1.4.2 Global NK-1 Receptor Antagonists Sales 2019-2030
1.4.3 Global NK-1 Receptor Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 NK-1 Receptor Antagonists Market Competition by Manufacturers
2.1 Global NK-1 Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global NK-1 Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global NK-1 Receptor Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of NK-1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NK-1 Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NK-1 Receptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of NK-1 Receptor Antagonists, Date of Enter into This Industry
2.8 Global NK-1 Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global NK-1 Receptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest NK-1 Receptor Antagonists Players Market Share by Revenue
2.8.3 Global NK-1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global NK-1 Receptor Antagonists Market Scenario by Region
3.1 Global NK-1 Receptor Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global NK-1 Receptor Antagonists Sales by Region: 2019-2030
3.2.1 Global NK-1 Receptor Antagonists Sales by Region: 2019-2024
3.2.2 Global NK-1 Receptor Antagonists Sales by Region: 2025-2030
3.3 Global NK-1 Receptor Antagonists Revenue by Region: 2019-2030
3.3.1 Global NK-1 Receptor Antagonists Revenue by Region: 2019-2024
3.3.2 Global NK-1 Receptor Antagonists Revenue by Region: 2025-2030
3.4 North America NK-1 Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.4.3 North America NK-1 Receptor Antagonists Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe NK-1 Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.5.3 Europe NK-1 Receptor Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NK-1 Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific NK-1 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific NK-1 Receptor Antagonists Sales by Region (2019-2030)
3.6.3 Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NK-1 Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.7.3 Latin America NK-1 Receptor Antagonists Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NK-1 Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa NK-1 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa NK-1 Receptor Antagonists Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NK-1 Receptor Antagonists Sales by Type (2019-2030)
4.1.1 Global NK-1 Receptor Antagonists Sales by Type (2019-2024)
4.1.2 Global NK-1 Receptor Antagonists Sales by Type (2025-2030)
4.1.3 Global NK-1 Receptor Antagonists Sales Market Share by Type (2019-2030)
4.2 Global NK-1 Receptor Antagonists Revenue by Type (2019-2030)
4.2.1 Global NK-1 Receptor Antagonists Revenue by Type (2019-2024)
4.2.2 Global NK-1 Receptor Antagonists Revenue by Type (2025-2030)
4.2.3 Global NK-1 Receptor Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global NK-1 Receptor Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global NK-1 Receptor Antagonists Sales by Application (2019-2030)
5.1.1 Global NK-1 Receptor Antagonists Sales by Application (2019-2024)
5.1.2 Global NK-1 Receptor Antagonists Sales by Application (2025-2030)
5.1.3 Global NK-1 Receptor Antagonists Sales Market Share by Application (2019-2030)
5.2 Global NK-1 Receptor Antagonists Revenue by Application (2019-2030)
5.2.1 Global NK-1 Receptor Antagonists Revenue by Application (2019-2024)
5.2.2 Global NK-1 Receptor Antagonists Revenue by Application (2025-2030)
5.2.3 Global NK-1 Receptor Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global NK-1 Receptor Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck NK-1 Receptor Antagonists Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 TerSera Therapeutics
6.2.1 TerSera Therapeutics Company Information
6.2.2 TerSera Therapeutics Description and Business Overview
6.2.3 TerSera Therapeutics NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 TerSera Therapeutics NK-1 Receptor Antagonists Product Portfolio
6.2.5 TerSera Therapeutics Recent Developments/Updates
6.3 Helsinn Healthcare
6.3.1 Helsinn Healthcare Company Information
6.3.2 Helsinn Healthcare Description and Business Overview
6.3.3 Helsinn Healthcare NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Helsinn Healthcare NK-1 Receptor Antagonists Product Portfolio
6.3.5 Helsinn Healthcare Recent Developments/Updates
6.4 Heron Therapeutics
6.4.1 Heron Therapeutics Company Information
6.4.2 Heron Therapeutics Description and Business Overview
6.4.3 Heron Therapeutics NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Heron Therapeutics NK-1 Receptor Antagonists Product Portfolio
6.4.5 Heron Therapeutics Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz NK-1 Receptor Antagonists Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Glenmark
6.6.1 Glenmark Company Information
6.6.2 Glenmark Description and Business Overview
6.6.3 Glenmark NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Glenmark NK-1 Receptor Antagonists Product Portfolio
6.6.5 Glenmark Recent Developments/Updates
6.7 Torrent Pharmaceuticals
6.7.1 Torrent Pharmaceuticals Company Information
6.7.2 Torrent Pharmaceuticals Description and Business Overview
6.7.3 Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Torrent Pharmaceuticals NK-1 Receptor Antagonists Product Portfolio
6.7.5 Torrent Pharmaceuticals Recent Developments/Updates
6.8 Steriscience
6.8.1 Steriscience Company Information
6.8.2 Steriscience Description and Business Overview
6.8.3 Steriscience NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Steriscience NK-1 Receptor Antagonists Product Portfolio
6.8.5 Steriscience Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan NK-1 Receptor Antagonists Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Company Information
6.10.2 Fresenius Kabi Description and Business Overview
6.10.3 Fresenius Kabi NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fresenius Kabi NK-1 Receptor Antagonists Product Portfolio
6.10.5 Fresenius Kabi Recent Developments/Updates
6.11 MSN
6.11.1 MSN Company Information
6.11.2 MSN Description and Business Overview
6.11.3 MSN NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MSN NK-1 Receptor Antagonists Product Portfolio
6.11.5 MSN Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva NK-1 Receptor Antagonists Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Eugia Pharma
6.13.1 Eugia Pharma Company Information
6.13.2 Eugia Pharma Description and Business Overview
6.13.3 Eugia Pharma NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Eugia Pharma NK-1 Receptor Antagonists Product Portfolio
6.13.5 Eugia Pharma Recent Developments/Updates
6.14 Lupin
6.14.1 Lupin Company Information
6.14.2 Lupin Description and Business Overview
6.14.3 Lupin NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lupin NK-1 Receptor Antagonists Product Portfolio
6.14.5 Lupin Recent Developments/Updates
6.15 Dr. Reddy's Laboratories
6.15.1 Dr. Reddy's Laboratories Company Information
6.15.2 Dr. Reddy's Laboratories Description and Business Overview
6.15.3 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product Portfolio
6.15.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.16 Chia Tai Tianqing Pharmaceutical
6.16.1 Chia Tai Tianqing Pharmaceutical Company Information
6.16.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.16.3 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.16.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.17 Qilu Pharmaceutical
6.17.1 Qilu Pharmaceutical Company Information
6.17.2 Qilu Pharmaceutical Description and Business Overview
6.17.3 Qilu Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Qilu Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.17.5 Qilu Pharmaceutical Recent Developments/Updates
6.18 Beijing Sihuan Pharmaceutical
6.18.1 Beijing Sihuan Pharmaceutical Company Information
6.18.2 Beijing Sihuan Pharmaceutical Description and Business Overview
6.18.3 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.18.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
6.19 Yichang Humanwell Pharmaceutical
6.19.1 Yichang Humanwell Pharmaceutical Company Information
6.19.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.19.3 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
6.19.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.20 Hansoh Pharma
6.20.1 Hansoh Pharma Company Information
6.20.2 Hansoh Pharma Description and Business Overview
6.20.3 Hansoh Pharma NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Hansoh Pharma NK-1 Receptor Antagonists Product Portfolio
6.20.5 Hansoh Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NK-1 Receptor Antagonists Industry Chain Analysis
7.2 NK-1 Receptor Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NK-1 Receptor Antagonists Production Mode & Process
7.4 NK-1 Receptor Antagonists Sales and Marketing
7.4.1 NK-1 Receptor Antagonists Sales Channels
7.4.2 NK-1 Receptor Antagonists Distributors
7.5 NK-1 Receptor Antagonists Customers
8 NK-1 Receptor Antagonists Market Dynamics
8.1 NK-1 Receptor Antagonists Industry Trends
8.2 NK-1 Receptor Antagonists Market Drivers
8.3 NK-1 Receptor Antagonists Market Challenges
8.4 NK-1 Receptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global NK-1 Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global NK-1 Receptor Antagonists Market Competitive Situation by Manufacturers in 2023
Table 4. Global NK-1 Receptor Antagonists Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global NK-1 Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 6. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global NK-1 Receptor Antagonists Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market NK-1 Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of NK-1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of NK-1 Receptor Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of NK-1 Receptor Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of NK-1 Receptor Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global NK-1 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK-1 Receptor Antagonists as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global NK-1 Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global NK-1 Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 18. Global NK-1 Receptor Antagonists Sales Market Share by Region (2019-2024)
Table 19. Global NK-1 Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 20. Global NK-1 Receptor Antagonists Sales Market Share by Region (2025-2030)
Table 21. Global NK-1 Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global NK-1 Receptor Antagonists Revenue Market Share by Region (2019-2024)
Table 23. Global NK-1 Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global NK-1 Receptor Antagonists Revenue Market Share by Region (2025-2030)
Table 25. North America NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 27. North America NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 28. North America NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America NK-1 Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 32. Europe NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 33. Europe NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe NK-1 Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific NK-1 Receptor Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific NK-1 Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific NK-1 Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 42. Latin America NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 43. Latin America NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global NK-1 Receptor Antagonists Sales (K Units) by Type (2019-2024)
Table 51. Global NK-1 Receptor Antagonists Sales (K Units) by Type (2025-2030)
Table 52. Global NK-1 Receptor Antagonists Sales Market Share by Type (2019-2024)
Table 53. Global NK-1 Receptor Antagonists Sales Market Share by Type (2025-2030)
Table 54. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Type (2019-2024)
Table 55. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Type (2025-2030)
Table 56. Global NK-1 Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 57. Global NK-1 Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 58. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2019-2024)
Table 59. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2025-2030)
Table 60. Global NK-1 Receptor Antagonists Sales (K Units) by Application (2019-2024)
Table 61. Global NK-1 Receptor Antagonists Sales (K Units) by Application (2025-2030)
Table 62. Global NK-1 Receptor Antagonists Sales Market Share by Application (2019-2024)
Table 63. Global NK-1 Receptor Antagonists Sales Market Share by Application (2025-2030)
Table 64. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Application (2019-2024)
Table 65. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Application (2025-2030)
Table 66. Global NK-1 Receptor Antagonists Revenue Market Share by Application (2019-2024)
Table 67. Global NK-1 Receptor Antagonists Revenue Market Share by Application (2025-2030)
Table 68. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2019-2024)
Table 69. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck NK-1 Receptor Antagonists Product
Table 74. Merck Recent Developments/Updates
Table 75. TerSera Therapeutics Company Information
Table 76. TerSera Therapeutics Description and Business Overview
Table 77. TerSera Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. TerSera Therapeutics NK-1 Receptor Antagonists Product
Table 79. TerSera Therapeutics Recent Developments/Updates
Table 80. Helsinn Healthcare Company Information
Table 81. Helsinn Healthcare Description and Business Overview
Table 82. Helsinn Healthcare NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Helsinn Healthcare NK-1 Receptor Antagonists Product
Table 84. Helsinn Healthcare Recent Developments/Updates
Table 85. Heron Therapeutics Company Information
Table 86. Heron Therapeutics Description and Business Overview
Table 87. Heron Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Heron Therapeutics NK-1 Receptor Antagonists Product
Table 89. Heron Therapeutics Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sandoz NK-1 Receptor Antagonists Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Glenmark Company Information
Table 96. Glenmark Description and Business Overview
Table 97. Glenmark NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Glenmark NK-1 Receptor Antagonists Product
Table 99. Glenmark Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Company Information
Table 101. Torrent Pharmaceuticals Description and Business Overview
Table 102. Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Torrent Pharmaceuticals NK-1 Receptor Antagonists Product
Table 104. Torrent Pharmaceuticals Recent Developments/Updates
Table 105. Steriscience Company Information
Table 106. Steriscience Description and Business Overview
Table 107. Steriscience NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Steriscience NK-1 Receptor Antagonists Product
Table 109. Steriscience Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan NK-1 Receptor Antagonists Product
Table 114. Mylan Recent Developments/Updates
Table 115. Fresenius Kabi Company Information
Table 116. Fresenius Kabi Description and Business Overview
Table 117. Fresenius Kabi NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Fresenius Kabi NK-1 Receptor Antagonists Product
Table 119. Fresenius Kabi Recent Developments/Updates
Table 120. MSN Company Information
Table 121. MSN Description and Business Overview
Table 122. MSN NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. MSN NK-1 Receptor Antagonists Product
Table 124. MSN Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Teva NK-1 Receptor Antagonists Product
Table 129. Teva Recent Developments/Updates
Table 130. Eugia Pharma Company Information
Table 131. Eugia Pharma Description and Business Overview
Table 132. Eugia Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Eugia Pharma NK-1 Receptor Antagonists Product
Table 134. Eugia Pharma Recent Developments/Updates
Table 135. Lupin Company Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Lupin NK-1 Receptor Antagonists Product
Table 139. Lupin Recent Developments/Updates
Table 140. Dr. Reddy's Laboratories Company Information
Table 141. Dr. Reddy's Laboratories Description and Business Overview
Table 142. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product
Table 144. Dr. Reddy's Laboratories Recent Developments/Updates
Table 145. Chia Tai Tianqing Pharmaceutical Company Information
Table 146. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 147. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product
Table 149. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 150. Qilu Pharmaceutical Company Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Qilu Pharmaceutical NK-1 Receptor Antagonists Product
Table 154. Qilu Pharmaceutical Recent Developments/Updates
Table 155. Beijing Sihuan Pharmaceutical Company Information
Table 156. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 157. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product
Table 159. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 160. Yichang Humanwell Pharmaceutical Company Information
Table 161. Yichang Humanwell Pharmaceutical Description and Business Overview
Table 162. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product
Table 164. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 165. Hansoh Pharma Company Information
Table 166. Hansoh Pharma Description and Business Overview
Table 167. Hansoh Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Hansoh Pharma NK-1 Receptor Antagonists Product
Table 169. Hansoh Pharma Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. NK-1 Receptor Antagonists Distributors List
Table 173. NK-1 Receptor Antagonists Customers List
Table 174. NK-1 Receptor Antagonists Market Trends
Table 175. NK-1 Receptor Antagonists Market Drivers
Table 176. NK-1 Receptor Antagonists Market Challenges
Table 177. NK-1 Receptor Antagonists Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of NK-1 Receptor Antagonists
Figure 2. Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global NK-1 Receptor Antagonists Market Share by Type: 2023 & 2030
Figure 4. Aprepitant Product Picture
Figure 5. Rolapitant Product Picture
Figure 6. Fosaprepitant Product Picture
Figure 7. Netupitant Product Picture
Figure 8. Maropitant Product Picture
Figure 9. Other Product Picture
Figure 10. Global NK-1 Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global NK-1 Receptor Antagonists Market Share by Application: 2023 & 2030
Figure 12. Chemotherapy-induced Nausea and Vomiting (CINV)
Figure 13. Postoperative Nausea and Vomiting (PONV)
Figure 14. Other
Figure 15. Global NK-1 Receptor Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global NK-1 Receptor Antagonists Market Size (2019-2030) & (US$ Million)
Figure 17. Global NK-1 Receptor Antagonists Sales (2019-2030) & (K Units)
Figure 18. Global NK-1 Receptor Antagonists Average Price (US$/Unit) & (2019-2030)
Figure 19. NK-1 Receptor Antagonists Report Years Considered
Figure 20. NK-1 Receptor Antagonists Sales Share by Manufacturers in 2023
Figure 21. Global NK-1 Receptor Antagonists Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest NK-1 Receptor Antagonists Players: Market Share by Revenue in NK-1 Receptor Antagonists in 2023
Figure 23. NK-1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global NK-1 Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 26. North America NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 27. United States NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 30. Europe NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 31. Germany NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific NK-1 Receptor Antagonists Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific NK-1 Receptor Antagonists Revenue Market Share by Region (2019-2030)
Figure 38. China NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 46. Mexico NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 52. Turkey NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of NK-1 Receptor Antagonists by Type (2019-2030)
Figure 56. Global Revenue Market Share of NK-1 Receptor Antagonists by Type (2019-2030)
Figure 57. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of NK-1 Receptor Antagonists by Application (2019-2030)
Figure 59. Global Revenue Market Share of NK-1 Receptor Antagonists by Application (2019-2030)
Figure 60. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2019-2030)
Figure 61. NK-1 Receptor Antagonists Value Chain
Figure 62. NK-1 Receptor Antagonists Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global NK-1 Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global NK-1 Receptor Antagonists Market Competitive Situation by Manufacturers in 2023
Table 4. Global NK-1 Receptor Antagonists Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global NK-1 Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 6. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global NK-1 Receptor Antagonists Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market NK-1 Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of NK-1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of NK-1 Receptor Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of NK-1 Receptor Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of NK-1 Receptor Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global NK-1 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK-1 Receptor Antagonists as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global NK-1 Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global NK-1 Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 18. Global NK-1 Receptor Antagonists Sales Market Share by Region (2019-2024)
Table 19. Global NK-1 Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 20. Global NK-1 Receptor Antagonists Sales Market Share by Region (2025-2030)
Table 21. Global NK-1 Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global NK-1 Receptor Antagonists Revenue Market Share by Region (2019-2024)
Table 23. Global NK-1 Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global NK-1 Receptor Antagonists Revenue Market Share by Region (2025-2030)
Table 25. North America NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 27. North America NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 28. North America NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America NK-1 Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 32. Europe NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 33. Europe NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe NK-1 Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific NK-1 Receptor Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific NK-1 Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific NK-1 Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 42. Latin America NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 43. Latin America NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global NK-1 Receptor Antagonists Sales (K Units) by Type (2019-2024)
Table 51. Global NK-1 Receptor Antagonists Sales (K Units) by Type (2025-2030)
Table 52. Global NK-1 Receptor Antagonists Sales Market Share by Type (2019-2024)
Table 53. Global NK-1 Receptor Antagonists Sales Market Share by Type (2025-2030)
Table 54. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Type (2019-2024)
Table 55. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Type (2025-2030)
Table 56. Global NK-1 Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 57. Global NK-1 Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 58. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2019-2024)
Table 59. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2025-2030)
Table 60. Global NK-1 Receptor Antagonists Sales (K Units) by Application (2019-2024)
Table 61. Global NK-1 Receptor Antagonists Sales (K Units) by Application (2025-2030)
Table 62. Global NK-1 Receptor Antagonists Sales Market Share by Application (2019-2024)
Table 63. Global NK-1 Receptor Antagonists Sales Market Share by Application (2025-2030)
Table 64. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Application (2019-2024)
Table 65. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Application (2025-2030)
Table 66. Global NK-1 Receptor Antagonists Revenue Market Share by Application (2019-2024)
Table 67. Global NK-1 Receptor Antagonists Revenue Market Share by Application (2025-2030)
Table 68. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2019-2024)
Table 69. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck NK-1 Receptor Antagonists Product
Table 74. Merck Recent Developments/Updates
Table 75. TerSera Therapeutics Company Information
Table 76. TerSera Therapeutics Description and Business Overview
Table 77. TerSera Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. TerSera Therapeutics NK-1 Receptor Antagonists Product
Table 79. TerSera Therapeutics Recent Developments/Updates
Table 80. Helsinn Healthcare Company Information
Table 81. Helsinn Healthcare Description and Business Overview
Table 82. Helsinn Healthcare NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Helsinn Healthcare NK-1 Receptor Antagonists Product
Table 84. Helsinn Healthcare Recent Developments/Updates
Table 85. Heron Therapeutics Company Information
Table 86. Heron Therapeutics Description and Business Overview
Table 87. Heron Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Heron Therapeutics NK-1 Receptor Antagonists Product
Table 89. Heron Therapeutics Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sandoz NK-1 Receptor Antagonists Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Glenmark Company Information
Table 96. Glenmark Description and Business Overview
Table 97. Glenmark NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Glenmark NK-1 Receptor Antagonists Product
Table 99. Glenmark Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Company Information
Table 101. Torrent Pharmaceuticals Description and Business Overview
Table 102. Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Torrent Pharmaceuticals NK-1 Receptor Antagonists Product
Table 104. Torrent Pharmaceuticals Recent Developments/Updates
Table 105. Steriscience Company Information
Table 106. Steriscience Description and Business Overview
Table 107. Steriscience NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Steriscience NK-1 Receptor Antagonists Product
Table 109. Steriscience Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan NK-1 Receptor Antagonists Product
Table 114. Mylan Recent Developments/Updates
Table 115. Fresenius Kabi Company Information
Table 116. Fresenius Kabi Description and Business Overview
Table 117. Fresenius Kabi NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Fresenius Kabi NK-1 Receptor Antagonists Product
Table 119. Fresenius Kabi Recent Developments/Updates
Table 120. MSN Company Information
Table 121. MSN Description and Business Overview
Table 122. MSN NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. MSN NK-1 Receptor Antagonists Product
Table 124. MSN Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Teva NK-1 Receptor Antagonists Product
Table 129. Teva Recent Developments/Updates
Table 130. Eugia Pharma Company Information
Table 131. Eugia Pharma Description and Business Overview
Table 132. Eugia Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Eugia Pharma NK-1 Receptor Antagonists Product
Table 134. Eugia Pharma Recent Developments/Updates
Table 135. Lupin Company Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Lupin NK-1 Receptor Antagonists Product
Table 139. Lupin Recent Developments/Updates
Table 140. Dr. Reddy's Laboratories Company Information
Table 141. Dr. Reddy's Laboratories Description and Business Overview
Table 142. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product
Table 144. Dr. Reddy's Laboratories Recent Developments/Updates
Table 145. Chia Tai Tianqing Pharmaceutical Company Information
Table 146. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 147. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product
Table 149. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 150. Qilu Pharmaceutical Company Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Qilu Pharmaceutical NK-1 Receptor Antagonists Product
Table 154. Qilu Pharmaceutical Recent Developments/Updates
Table 155. Beijing Sihuan Pharmaceutical Company Information
Table 156. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 157. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product
Table 159. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 160. Yichang Humanwell Pharmaceutical Company Information
Table 161. Yichang Humanwell Pharmaceutical Description and Business Overview
Table 162. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product
Table 164. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 165. Hansoh Pharma Company Information
Table 166. Hansoh Pharma Description and Business Overview
Table 167. Hansoh Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Hansoh Pharma NK-1 Receptor Antagonists Product
Table 169. Hansoh Pharma Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. NK-1 Receptor Antagonists Distributors List
Table 173. NK-1 Receptor Antagonists Customers List
Table 174. NK-1 Receptor Antagonists Market Trends
Table 175. NK-1 Receptor Antagonists Market Drivers
Table 176. NK-1 Receptor Antagonists Market Challenges
Table 177. NK-1 Receptor Antagonists Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of NK-1 Receptor Antagonists
Figure 2. Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global NK-1 Receptor Antagonists Market Share by Type: 2023 & 2030
Figure 4. Aprepitant Product Picture
Figure 5. Rolapitant Product Picture
Figure 6. Fosaprepitant Product Picture
Figure 7. Netupitant Product Picture
Figure 8. Maropitant Product Picture
Figure 9. Other Product Picture
Figure 10. Global NK-1 Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global NK-1 Receptor Antagonists Market Share by Application: 2023 & 2030
Figure 12. Chemotherapy-induced Nausea and Vomiting (CINV)
Figure 13. Postoperative Nausea and Vomiting (PONV)
Figure 14. Other
Figure 15. Global NK-1 Receptor Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global NK-1 Receptor Antagonists Market Size (2019-2030) & (US$ Million)
Figure 17. Global NK-1 Receptor Antagonists Sales (2019-2030) & (K Units)
Figure 18. Global NK-1 Receptor Antagonists Average Price (US$/Unit) & (2019-2030)
Figure 19. NK-1 Receptor Antagonists Report Years Considered
Figure 20. NK-1 Receptor Antagonists Sales Share by Manufacturers in 2023
Figure 21. Global NK-1 Receptor Antagonists Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest NK-1 Receptor Antagonists Players: Market Share by Revenue in NK-1 Receptor Antagonists in 2023
Figure 23. NK-1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global NK-1 Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 26. North America NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 27. United States NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 30. Europe NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 31. Germany NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific NK-1 Receptor Antagonists Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific NK-1 Receptor Antagonists Revenue Market Share by Region (2019-2030)
Figure 38. China NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 46. Mexico NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa NK-1 Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 52. Turkey NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE NK-1 Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of NK-1 Receptor Antagonists by Type (2019-2030)
Figure 56. Global Revenue Market Share of NK-1 Receptor Antagonists by Type (2019-2030)
Figure 57. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of NK-1 Receptor Antagonists by Application (2019-2030)
Figure 59. Global Revenue Market Share of NK-1 Receptor Antagonists by Application (2019-2030)
Figure 60. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2019-2030)
Figure 61. NK-1 Receptor Antagonists Value Chain
Figure 62. NK-1 Receptor Antagonists Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232